Current evidence suggests that loss of AAT in salivary gland cells with a consequent increase in elastase expression could contribute to the initiation of primary Sjogren’s syndrome [183], although the efficacy of AAT replacement therapy in this condition has not been assessed. Here, SERPINA1 is linked to Sjogren syndrome.